Profiel
Steven A. Cantor is the founder of Vaso Corp.
and bioAffinity Technologies, Inc. He previously worked as the Manager of Business Development at Neurox Pharmaceuticals LLC from 2011 to 2014, Co-Chief Executive Officer & Director at enVVeno Medical Corp.
from 2017 to 2018, and Chairman at Crown Equity Holdings, Inc. in 2018 to 2019.
Eerdere bekende functies van Steven Cantor
| Bedrijven | Functie | Einde |
|---|---|---|
| CROWN EQUITY HOLDINGS INC. | Voorzitter | 09-01-2019 |
| ENVVENO MEDICAL CORPORATION | Algemeen Directeur | 01-04-2018 |
| BIOAFFINITY TECHNOLOGIES, INC. | Oprichter | 01-05-2014 |
Neurox Pharmaceuticals LLC
Neurox Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Corporate Officer/Principal | 01-01-2014 |
| VASO CORPORATION | Algemeen Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Vaso Corp.
Vaso Corp. Information Technology ServicesTechnology Services Engages in the healthcare equipment and information technology industries | Technology Services |
enVVeno Medical Corp.
enVVeno Medical Corp. Medical SpecialtiesHealth Technology Specializes in biological cardiovascular implants | Health Technology |
Crown Equity Holdings, Inc.
Crown Equity Holdings, Inc. Advertising/Marketing ServicesCommercial Services Operates as a holding company whose subsidiaries provides computer related services | Commercial Services |
bioAffinity Technologies, Inc.
bioAffinity Technologies, Inc. Medical SpecialtiesHealth Technology Develops vitro diagnostic tests and targeted cancer therapeutics for early-stage cancer diagnostics | Health Technology |
Neurox Pharmaceuticals LLC
Neurox Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
















